Enhanced Dual-Action Immunotherapy in CAR-T Cells Boosts Control of B-ALL Progression
B-cell acute lymphoblastic leukemia (B-ALL) remains the most prevalent pediatric cancer, representing approximately 85% of all leukemia diagnoses in children. ...
Tag: long-term remission challenges in B-ALL
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!